According to the World Health Organisation, over 160 vaccine candidates are in pre-clinical or clinical trials at present, 29 of them are in the clinical trials phase. At least eight candidate vaccines are being developed in India of which two are in phase -II trial phase. The latest to create ripples is Russia which recently announced giving a regulatory approval for the “Sputnik V” vaccine for Covid-19. Also read: ‘Made in India Covid-19 vaccine soon’ - PM Modi in Independence Day speechOxford University’s Covid-19 vaccine trial, which is in phase-III, is expected to get completed by the end of this year. Pune-based vaccine manufacturer Serum Institute of India (SII) has already received a nod from for India’s top drug regulatory body for conducting phase-II and III clinical trials on the Oxford Covid-19 vaccine.

Source: Hindustan Times August 15, 2020 10:23 UTC